Citation

Palmer S, Davidson K, Tyrer P, Gumley A, Tata P, Norrie J, Murray H, Seivewright H. J. Personal. Disord. 2006; 20(5): 466-481.

Copyright

(Copyright © 2006, Guilford Publications)

DOI

10.1521/pedi.2006.20.5.466

PMID

17032159

PMCID

PMC1852260

Abstract

Borderline personality disorder places a significant burden on healthcare providers and other agencies. This study evaluated the cost-effectiveness of cognitive behavior therapy plus treatment as usual compared to treatment as usual alone for patients with borderline personality disorder. The economic analysis was conducted alongside a multi-center, randomized controlled trial. The costs of primary and secondary healthcare utilization, alongside the wider economic costs, were estimated from medical records and patient self-report. The primary outcome measure used was the quality-adjusted life year (QALY), assessed using EuroQol. On average, total costs per patient in the cognitive behavior therapy group were lower than patients receiving usual care alone (-689 pounds sterling), although this group also reported a lower quality of life (-0.11 QALYs). These differences were small and did not approach conventional levels of statistical significance. The use of cognitive therapy for borderline personality disorder does not appear to demonstrate any significant cost-effective advantage based on the results of this study.

Language: en

Keywords

Adult; Aged; Ambulatory Care; Anxiety; Borderline Personality Disorder; Cognitive Behavioral Therapy; Cost-Benefit Analysis; Female; Humans; Male; Middle Aged; Outpatients; Quality-Adjusted Life Years; Reproducibility of Results; Self-Injurious Behavior; Social Adjustment; Suicide Prevention; Treatment Outcome